Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 921932Generated: October 30, 2026

Isopropanol → (R)-methyl (1-(2-chloro-5-cyano-3-((7-cyano-4-(ethylamino)imidazo[2,1-f][1,2,4]triazin-2-yl)amino)phenyl)-3-oxopiperidin-4-yl)carbamate

https://huagongshe.com/reaction/921932

Reaction equation

Participants

RoleNameHCIDCharge
ReactantIsopropanolHCID 3776—
ReactantAmmonium ChlorideHCID 25517—
ReactantTriacetoxyperiodinaneHCID 159087—
ReactantSodium BicarbonateHCID 516892—
ReactantAmmonium AcetateHCID 517165—
Reactantmethyl ((3R,4R)-1-(2-chloro-5-cyano-3-((7-cyano-4-(ethylamino)imidazo[2,1-f][1,2,4]triazin-2-yl)amino)phenyl)-3-hydroxypiperidin-4-yl)carbamateHCID 89932121—
SolventDimethyl SulfoxideHCID 679—
SolventWaterHCID 962—
SolventAcetonitrileHCID 6342—
Product(R)-methyl (1-(2-chloro-5-cyano-3-((7-cyano-4-(ethylamino)imidazo[2,1-f][1,2,4]triazin-2-yl)amino)phenyl)-3-oxopiperidin-4-yl)carbamateHCID 89934113—

Reaction Steps

A 4 ml vial was loaded with methyl ((3R,4R)-1-(2-chloro-5-cyano-3-((7-cyano-4-(ethylamino)imidazo[2,1-f][1,2,4]triazin-2-yl)amino)phenyl)-3-hydroxypiperidin-4-yl)carbamate (Example 328) (31 mg, 0.061 mmol) and Dess-Martin Periodinane (52 mg, 0.123 mmol). DMSO (1 ml) was added (complete dissolution of starting material). The reaction mixture was stirred at room temperature for 1.5 hours. The reaction was quenched by addition of 2-Propanol (0.10 ml, 1.298 mmol). The reaction mixture was poured into a dilute solution of NaHCO3 and NH4Cl in water. The product precipitated as an off-white solid, which was collected by filtration, washed with water and dried in an air-stream. An analytically pure sample was obtained via purification by prep HPLC with the following conditions: Column: XBridge C18, 19×mm, 5-μm particles; Mobile Phase A: 5:95 acetonitrile: water with 10-mM ammonium acetate; Mobile Phase B: 95:5 acetonitrile: water with 10-mM ammonium acetate; Gradient: 20-80% B over 20 minutes, then a 0-minute hold at 100% B; Flow: 20 mL/min. Fractions containing the desired product were combined and dried via centrifugal evaporation. The material was further purified via preparative LC/MS with the following conditions: Column: XBridge C18, 19×mm, 5-μm particles; Mobile Phase A: 5:95 acetonitrile: water with 10-mM ammonium acetate; Mobile Phase B: 95:5 acetonitrile: water with 10-mM ammonium acetate; Gradient: 25-65% B over 20 minutes, then a 5-minute hold at 100% B; Flow: 20 mL/min. Fractions containing the desired product were combined and dried via centrifugal evaporation to give (R)-methyl (1-(2-chloro-5-cyano-3-((7-cyano-4-(ethylamino)imidazo[2,1-f][1,2,4]triazin-2-yl)amino)phenyl)-3-oxopiperidin-4-yl)carbamate (4.2 mg). The product exists as a mixture of ketone and hydrate (and if analyzed in MeOH solution also mono- and dimethyl-acetal)

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09273057B2
Source datasetuspto-grants-2016_03
ORD IDord-59fe50185fb44262bc35ed812265a2b3
Source noteuspto-grants-2016_03